RUTGERS, THE STATE UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Trial of ctDNA of Guidance to Determine PostOperative Radiation Therapy

Early Phase 1

Not yet recruiting

Conditions: Lung Cancer
Non Small Cell Lung Cancer
Lung Cancer Recurrent

First Posted Date: 2025-05-20

Last Posted Date: 2025-05-20

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 25

Registration Number: NCT06979661

Locations: 🇺🇸
Rutgers Cancer Institute, New Brunswick, New Jersey, United States

Project COMET: Massed Prolonged Exposure for PTSD and SUD

Not Applicable

Not yet recruiting

Conditions: Posttraumatic Stress Disorder (PTSD)
Substance Use Disorders (SUD)
Comorbidity
Trauma and Stressor Related Disorders

First Posted Date: 2025-05-13

Last Posted Date: 2025-05-13

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 168

Registration Number: NCT06968832

Locations: 🇺🇸
Gateway Community Services, Jacksonville, Florida, United States

Lactate and Glycerol Contribution to Gluconeogenesis

Phase 1

Not yet recruiting

Conditions: Type 2 Diabetes
Obesity
Healthy

Interventions: Drug: Glycerol
Drug: Glucose
Drug: Lactate

First Posted Date: 2025-05-02

Last Posted Date: 2025-05-13

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 48

Registration Number: NCT06955130

Metabolic Health, Bones and Nuts During Weight Loss in Adults

Not Applicable

Recruiting

Conditions: Weight Loss
Bone Density
Obesity and Overweight

First Posted Date: 2025-04-29

Last Posted Date: 2025-04-29

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 44

Registration Number: NCT06949280

Locations: 🇺🇸
Rutgers University - NJ Inst Food Nutrition & Health, New Brunswick, New Jersey, United States

Effects of FDA Authorized Smokeless Tobacco Claims Among US Adults Who Smoke Cigarettes

Not Applicable

Completed

Conditions: Tobacco Product Beliefs and Use

First Posted Date: 2025-04-15

Last Posted Date: 2025-05-21

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 1257

Registration Number: NCT06927700

Locations: 🇺🇸
Rutgers Institute for Nicotine & Tobacco Studies, New Brunswick, New Jersey, United States

Diabetes Electronic Prompt for Improved Care Coordination and Treatment in the ED

Not Applicable

Recruiting

Conditions: Type 2 Diabetes
Type 2 Diabetes Mellitus (T2DM)
Hyperglycemia
Insulin Dependent Diabetes

First Posted Date: 2025-03-27

Last Posted Date: 2025-05-07

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 200

Registration Number: NCT06899191

Locations: 🇺🇸
Rutgers, Robert Wood Johnson Hospital, New Brunswick, New Jersey, United States

Effects of Latin Dancing on Sleep Quality in Hispanic Cancer Survivors

Not Applicable

Not yet recruiting

Conditions: Cancer Survivorship
Sleep Disturbances

First Posted Date: 2025-02-25

Last Posted Date: 2025-02-25

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 40

Registration Number: NCT06844981

Locations: 🇺🇸
Rutgers Cancer Institute, New Brunswick, New Jersey, United States

Bite Force Measurements

Recruiting

Conditions: Irreversible Pulpitis
Apical Periodontitis
Pulpal Necrosis

First Posted Date: 2025-02-25

Last Posted Date: 2025-05-18

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 112

Registration Number: NCT06843525

Locations: 🇺🇸
Rutgers School of Dental Medicine, Newark, New Jersey, United States

Advancing Care Coordination Between Cancer and Primary Care Teams for Complex Cancer Survivors

Not Applicable

Not yet recruiting

Conditions: Cancer
Breast Cancer Early Stage Breast Cancer (Stage 1-3)
Bladder Cancer
Prostate Cancer (Adenocarcinoma)
Endometrial Cancer
Hypertension
Hyperlipidemia (E.G., Hypercholesterolemia)
Diabetes Mellitus

First Posted Date: 2025-02-19

Last Posted Date: 2025-02-19

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 266

Registration Number: NCT06834204

Locations: 🇺🇸
Rutgers RWJ Medical School, Somerset, New Jersey, United States

SeqUential GeMcitabine and MITomycin Treatment for Favorable High-Risk Upper Urinary Tract Urothelial Carcinoma

Phase 2

Not yet recruiting

Conditions: Urinary Bladder Cancer
Upper Tract Urothelial Cancer
Urothelial Cancer

Interventions: Drug: Sequential Gemcitabine and Jelmyto Treatment (Gem/Jel)

First Posted Date: 2025-02-12

Last Posted Date: 2025-02-12

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 28

Registration Number: NCT06822010

Home Terms & Conditions Privacy Policy